Regular Thyroid Screening Recommended for People With Hepatitis C
People with hepatitis C are at an increased risk for several autoimmune disorders. Researchers sought to discover a link between the virus and hypothyroidism.
Hepatology Information Center
Atypical Celiac Disease: Diagnosing Nonintestinal Cases in Primary Care
Atypical celiac disease may present as dermatitis herpetiformis, anemia, elevated transaminases, short stature, and osteopenia/osteoporosis.
HCV Treatment Declined Nearly Twofold Between 2015 and 2020
The COVID-19 pandemic and opioid crisis created new barriers to HCV treatment, leading to the lowest annual treatment rate in 5 years.
Top November & December 2021 FDA Approvals
November and December 2021 FDA drug approvals include treatments for hepatitis B, achondroplasia, cancer, and polycythemia vera.
Hepatitis B Shots Advised for All US Adults Younger Than 60 Years
Until now, the shots were recommended only for certain groups of adults.
Medication Treatments Lacking for Active Opioid Use Disorder in Veterans With Cirrhosis
Investigators assessed the factors associated with medication treatment for opioid use disorder and whether it is linked to hepatic decompensation or death in patients with cirrhosis and active opioid use disorder.
Challenges in Managing Increasing Infection Rates in Cirrhosis
The natural history of cirrhosis is significantly affected by the increasing prevalence of infections, with strategies for prevention and treatment difficult to compose.
Sleep-Wake Disturbance Highly Prevalent in Populations With Liver Disease
Researchers summarized the reciprocal interaction between sleep and liver diseases, including cirrhosis, and investigated potential approaches for therapeutic interventions.
Epstein-Barr Virus: Forgotten Etiology of Hepatic Injury
Epstein-Barr virus infection may present with liver injury characterized by acute cholestatic hepatitis, as demonstrated in this case.
Pharmacotherapies for Liver Fibrosis, NASH Resolution Ranked
Although NASH is a common cause of chronic liver disease, there is limited evidence surrounding its management.
Opioid Agonist Therapy Linked to Increased HCV Treatment Rates in People Who Inject Drugs
Researchers studied the impact of current opioid agonist therapy on initiation of chronic hepatitis C virus treatment among a population of individuals who inject drugs.
Better Strategies Needed for Managing NAFLD in Adults
Needs assessment survey conducted in response to increasing clinical burden of nonalcoholic fatty liver disease, nonalcoholic steatohepatitis
Acute-on-Chronic Liver Failure: Comparing First-Line Antivirals in Chronic HBV
Investigators conducted an ongoing prospective cohort study to better understand the safety and efficacy of nucleoside and/or nucleotide analogs among patients with hepatitis B virus-related acute-on-chronic liver failure.
Seroclearance of Hepatitis B Surface Antigens by 10 Years Rare After Antiviral Therapies
Investigators estimated the incidence of HBsAg seroclearance in patients with hepatitis B virus infection on long-term therapy with entecavir or tenofovir disoproxil fumarate.
Hepatitis B Virus Monitoring Needed After Liver Transplantation
While the risk is small, there have been 20 cases of unexpected donor-derived hepatitis B virus infection
HBV Suppression Lowers Liver Cancer Rates in Patients Coinfected With HIV
Findings emphasize the importance of strategies to help HBV-HIV coinfected patients maximize antiretroviral adherence to achieve hepatitis B viral suppression.
Opt-Out Increases Hepatitis C Screening Uptake
Eligible patients more likely to complete HCV screening if order is included with reminder
Pediatric Hexavalent Combination Vaccine Vaxelis Now Available
Vaxelis is the first hexavalent combination vaccine indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b.
Antiviral Therapy Reduces Cirrhosis Risk in Patients With Chronic HBV
The finding of a reduce risk of cirrhosis in patients with chronic HBV on antiviral therapy underscores the importance of early treatment.
Tenofovir Disoproxil Fumarate Shows Long-Term Safety in Infants
Investigators analyzed the safety of tenofovir disoproxil fumarate therapy during the third trimester of pregnancy.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Hepatology Information Center
Loading... 
Loading...